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ABSTRACT
Introduction. Cardiologic diagnostics in stroke patients is designed to identify heart disease as a potential cause of stroke. The 
aim of this study was to evaluate the effect of low ejection fraction (EF) and left ventricular systolic/diastolic dysfunction (LVSD, 
LVDD) on the neurological state on the 1st day of stroke, as well as post-stroke functional status at 30 days after stroke. 
Patients and methods. For a prospective study, 162 stroke patients (mean age 74 years) were qualified. They were analysed 
according to neurological state on the 1st day of stroke, the results of transthoracic echocardiography, and functional status at 
30 days after stroke.
Results. The neurological state on the 1st day after stroke was significantly worse in patients with LVSD. In patients with reduced 
EF, functional status was significantly worse at 30 days after stroke. Patients with E/A 0.8–2 had a significantly worse functional 
status compared to patients with E/A < 0.8. Individuals with E/A 0.8–2 and segmental LVSD or EF < 50% had significantly worse 
functional status compared to patients without LVSD. An independent factor for moderate/severe status was identified: E/A > 
0.8 (RR 3.28 [95% CI 1.15-9.37]); independent factors for poor functional status were lower EF (RR 4.68 [95% CI 1.22–18.00]) and 
age (RR 4.68 [95% CI 1.22–11.00]).
Conclusions. One quarter of patients in the acute phase of stroke have LVSD and/or LVDD. LVSD adversely affects both neu-
rological status in acute stroke as well as functional status in the short-term follow-up. Age at first-in-life stroke incidence and 
lower EF are predictors of poor functional status one month after a stroke.
Key words: stroke, cardiac dysfunction, fraction ejection, mRankin 
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Introduction
Cardiologic diagnostics in stroke patients is designed to 
identify the presence of heart disease as a potential cause of 
acute cerebral ischaemia and to estimate the risk of stroke re-
currence, which is high in patients with myocardial contractile 
dysfunction and/or thrombosis in the cavities of the heart. 
Although left ventricular dysfunction (LVD) is considered to 
be an independent risk factor for stroke, the results of several 
studies have not shown any significant increase in embolic in-
cidence in patients with LVD [1–3]. A possible explanation for 
the discrepancies in research results is the type of anticoagulant 
therapy used that modifies the risk of cerebral and/or systemic 
embolism to varying degrees. The adverse effect of LVD on 
the status of patients with chronic stroke has been reported. 
However, the importance of LVD for neurological status in the 
early period of stroke onset has not been clearly established. 
Given the haemodynamic effects of LVD in the cerebral circu-
lation, the effect of worsening hypoperfusion in the ischaemic 
zone is to be expected.
The aim of this study was to evaluate the potential effect of 
low ejection fraction (EF), and segmental systolic dysfunction 
and left ventricular diastolic dysfunction, on the neurologi-
cal state of patients on the 1st day after stroke onset, as well 
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as post-stroke functional status at 30 days after stroke. An 
additional objective was to evaluate the significance of other 
cardiac echocardiographic parameters in acute stroke and the 
short-term prognosis in this group of patients.
Methods
For a prospective study covering the period 2015–2016 in 
the Neurology Department, 162 patients (77 women, 85 men), 
mean age 74 years (71.9 ± 12.6) [25–96] were classified, with 
the first clinically manifested stroke identified according to the 
WHO clinical criteria and visible in neuroimaging (computed 
tomography and/or magnetic resonance imaging of the head) 
acute ischaemic lesion of the brain [1]. Other main inclusion 
criteria were: time from onset of stroke symptoms to hospital 
admission ≤ 24 hours; and the pre-stroke status according to 
the modified Rankin Scale (mRS) ≤ 1 point.
All patients included in the study were analysed accor-
ding to:
 — age when they had their first-in-life stroke
 — presence of comorbidities such as atrial fibrillation (AF), 
arterial hypertension (AH), coronary heart disease (CHD), 
diabetes mellitus (DM) and lipid disorders (LD), > 70% 
atherosclerotic carotid stenosis (ipsilaterally to the ischa-
emic brain lesion)
 — neurological state on the 1st day after stroke onset eva-
luated according to NIHSS (National Institute of Health 
Stroke Scale) [3]
 — anatomic location of stroke (total anterior cerebral infarct, 
TACI); partial anterior CI (PACI), lacunar CI (LACI), and 
posterior CI (POCI)
 — early therapeutic management in the acute stage of stroke 
(thrombolytic intravenous (rtPA iv), endovascular throm-
bectomy, antiplatelet treatment)
 — the results of transthoracic echocardiography (TTE) within 
the first two days of stroke onset, including heart cavity 
dimensions, left ventricular contractility and valvular fun-
ction evaluated according to the recommendations of the 
European Association of Cardiovascular Imaging (EACVI)
 — functional status at 30 days after stroke according to the 
mRS scale (based on information obtained from the patient 
and/or carer during a phone call [4].
Diagnosis of AH was consistent with the recommendations 
of the European Society of Cardiology (ESC), DM was diagno-
sed according to the criteria of the Diabetes Association, dysli-
pidaemia was defined according to the ESC recommendations 
(Guidelines for the Management of Dyslipidaemias) [4–6].
The degree of stenosis of common carotid artery and/or 
internal carotid artery was assessed according to the NASCET 
criteria [7]. The TTE was performed using the Philips Epiq 7.
The patients were divided into groups depending on the 
presence of segmental contractility abnormalities (patients with 
present vs absent contractility dysfunction), ejection fraction 
(EF < 50% vs ≥ 50%), left atrial size (LA ≤ 40 mm vs > 40 mm), 
left ventricular end-diastolic dimension (EDD  <  56  mm 
vs ≥ 56 mm), mitral regurgitation degree (MR 1 + 2 vs 3), aor-
tic stenosis degree (AS 1 + 2 vs 3), aortic regurgitation degree 
(AR 1 + 2 vs 3), relative wall thickness (patients with present 
vs absent hypertrophy) or eccentric hypertrophy (patients 
with present vs absent eccentric hypertrophy). In these groups, 
mean scores for NIHSS (neurological state on the 1st day after 
stroke onset) and mRS (functional status at 30 days after stroke 
onset) were calculated, and a comparison was made between 
subgroups. Next, 113 patients without atrial fibrillation were 
divided into three groups depending on the rate of mitral 
inflow E to A: group A: E/A ratio ≤ 0.8 - patients with impai-
red LV relaxation; group B, which included patients with no 
abnormalities or with pseudo-normal pattern of mitral inflow: 
E/A 0.8-2; and group C - patients with restricted mitral inflow 
pattern: E/A > 2. In these groups, mean scores for NIHSS were 
calculated (on the 1st day after stroke), and mRS (at 30 days 
after stroke), and a comparison was made between the groups.
For the identification of patients with left ventricular 
diastolic dysfunction with pseudo-normal pattern of mitral 
inflow, patients in group B were divided into two subgroups 
according to the following criteria: B1 — patients with E/A 
ratio 0.8–2, present segmental contractility dysfunction and/
or EF < 50%; subgroup B2 — patients with E/A 0.8–2, absence 
of segmental contractility dysfunction and normal EF (> 50%). 
Neurological status according to NIHSS (24h after stroke 
onset), and functional status according to mRS (30 days after 
stroke onset) were assessed in subgroups B1 and B2 and the 
mean values obtained were compared. Multi-factorial analysis 
was performed to determine independent factors of bad neu-
rological status on the 1st day (NIHSS > 10 points) and poor 
prognosis defined as the patient receiving 3–6 points on mRan-
kin Scale at 30 days after stroke. The following parameters 
were included in the analysis: age, sex, arterial hypertension, 
diabetes mellitus, coronary heart disease, atrial fibrillation, 
lipid abnormalities, > 70% carotid stenosis, location of stroke 
(PACI, TACI, POCI, LACI), therapeutic management in the 
acute stage of stroke (reperfusion therapy- rtPA or/and throm-
bectomy, antiplatelet therapy without reperfusion strategies), 
EF reduction, size of LA, AS, MR, RWT, EDD, and NIHSS 24h 
after stroke for the identification of prognostic factors for one 
month after the onset of stroke.
All statistical analyses were performed using STATISTICA 
8.0 PL software. Chi-square and Student’s tests were used for 
categorical variables. The Mann-Whitney U test was used 
to compare the study groups and subgroups for the nonpa-
rametric distribution of some of the parameters. Finally, an 
analysis was made using a single and multi-factorial method 
of nonlinear estimation — logistic regression (STATISTICA 
5.0PL) — to identify independent factors for moderate/severe 
neurological state and post-stroke disability at 30 days after 
stroke. P < 0.05 was considered statistically significant. 
Ethical approval was not necessary for preparation of 
this article. 
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Results
The baseline characteristics of patients enrolled in the 
study are presented in Table 1.
The neurological state on the 1st day after stroke was 
significantly worse in patients with left ventricular contractile 
dysfunction. In patients with reduced ejection fraction asses-
sed within the first two days after stroke functional status at 
30 days after stroke was significantly worse. In patients with 
left ventricular hypertrophy and/or left atrial enlargement, 
both neurological and functional status was worse, but the 
differences relative to patients with normal LV and LA were 
not statistically significant (Tab. 2).
Patients with E/A ratio 0.8–2 had a significantly worse 
functional status after one month of stroke onset compared 
to patients with E/A < 0.8 (Tab. 3).
Patients with E/A 0.8–2 and LV contractile dysfunction 
LVSD and/or EF < 50% had significantly worse outcomes in 
functional status assessment compared to patients without LV 
systolic dysfunction (Tab. 4).
In multi-factorial analysis, only one independent factor 
— E/A > 0.8 (RR 3.28 [95% CI 1.15–9.37] p < 0.0208) was 
identified for moderate/severe neurological status (NIHSS 
> 10 points) on the 1st day of stroke. There were two independ-
ent factors for poor functional status prognosis (3–6 mRankin) 
at 30 days after stroke: lower EF (RR 4.68 [95% CI 1.22–18.00], 
p 0.0186) and age RR 4.68 [95% CI 1.22–11.00], p < 0.0179. 
The other analysed clinical and echocardiographic parameters 
were not independent factors for patients’ state.
Discussion
In the present study, abnormal echocardiographic para-
meters indicating structural and/or functional myocardial 
dysfunction were found in 23% of patients. The most important 
result of the present study is the finding of unfavourable effects 
of both systolic and diastolic left ventricular dysfunction on 
the course of stroke. The significance of selected LVD para-
meters for stroke patient status varies and is marked both on 
the 1st day after stroke as well as one month after the onset of 
symptoms. Knowledge of the presence of cardiac dysfunction 
in a stroke patient is not only important for prognosis but may 
be crucial for planning early and subsequent rehabilitation. 
Population studies estimate the incidence of left ventri-
cular dysfunction to be about 15 –25%, including 0.9–6% of 
patients who are asymptomatic [8–11]. LVD is more common 
in people > 65 years of age, and in the subpopulation of pa-
tients with arterial hypertension and diabetes [8]. Older age, 
hypertension and diabetes also increase the risk of stroke. LVD 
is a consequence of cardiomyocyte death because of oxidative 
stress originating in the cardiomyocytes as a result of ischae-
mia, infection, or toxicity [12]. Clinical manifestations of heart 
failure such as dyspnoea and reduced exercise tolerance are 
more common in left ventricle diastolic dysfunction (LVDD). 
Table 1. Characteristics of the patients
Parameter Group n = 162
Age 71.9 ± 12.6 
[25–96] median 74
Sex  F/M 77/85
DM 46 (28.4%)
AH 143 (88.3%)
AF 49 (30.2%)
AF de novo 14 (8.6%)
MI 28 (17.3%)
Location of stroke
TACI
PACI
LACI
POCI
69 (42.6%)
40 (24.7%)
44 (27.2%)
9 (5.6%)
rtPA-therapy
thrombectomy 
antiplatelet without reperfu-
sion therapy
38 (23.6%)
6 (3.7%)
117 (72.7%)
F — female, M — male, DM — diabetes mellitus, AH — arterial hypertension, AF — atrial fibrilla-
tion, MI — past myocardial infarct, PACI — partial anterior cerebral infarct, TACI — total anterior 
cerebral infarct, POCI — posterior cerebral infarct, LACI — lacunar cerebral infarct, rtPA — recombi-
ned tissue plasminogen activator
This means that many patients may be unaware of their cardiac 
contractility dysfunctions, and according to the Framingham 
study the mortality rate of patients with left ventricular systolic 
dysfunction is higher, and it constitutes 17.9% (compared to 
8.9% in patients with diastolic dysfunction, and 3.7% in the 
control group) [13].
Based on a multivariate analysis, the presence of moderate 
or severe LVSD in two-dimensional echocardiography has 
been shown to increase the prevalence of an acute embolic 
event, including stroke [14, 15]. Contractile disorders have also 
been associated with the risk of stroke recurrence [16]. Park 
et al. [17] reported LVD in more than half of stroke patients, 
including profound dysfunction in every tenth stroke patient. 
In such cases, LVD may impede functional recovery of stroke 
survivors due to their lower exercise capacity.
An adverse implication of limited rehabilitation, regardless 
of other comorbid diseases, may be the worse post-stroke 
functional state of stroke survivors. The results of this study 
indicate that the neurological status on the 1st day after stroke 
in patients with LVSD was significantly worse than in patients 
with normal LV function. The consequence of haemodynamic 
insufficiency associated with LVSD is cerebral hypoperfusion. 
This impedes the already impaired blood flow in the penumbra 
area surrounding the cerebral infarction lesion. Other coe-
xisting disorders such as impaired cerebral autoregulation, 
endothelial dysfunction, prothrombotic state, and infection 
additionally adversely affect the evolution of the cerebral 
ischaemic lesion [18–20]. Also, the effect of reperfusion in 
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ventricular diastolic dysfunction. The effect of LVDD was in-
dependent of coexisting LVLD and EF reduction. It has been 
previously shown that LVDD, independent of the coexistence 
of AF, increases the incidence of vascular events and deterio-
rates patients’ status at 3 and 12 months after stroke [17]. The 
the penumbra zone can be reduced in the presence of left 
ventricular dysfunction.
According to the results of the present study, an adverse 
effect on the neurological status on the 1st day after stroke 
was also brought about by impaired LV filling, indicating left 
Table 2. Neurological status on the 1st day and functional status at 30 days after stroke onset according to selected echocardiographic parameters
Parameter, n NIHSS p mRankin p
Segmental contractility LV
normal, n = 127
abnormal, n = 35
3.74 ± 4.65
5.40 ± 4.60
0.013 2.29 ± 1.76
2.83 ± 1.82
0.10090
EF
< 50, n = 23
≥ 50, n = 139
5.67 ± 5.19
3.93 ± 4.69
0.054 3.08 ± 1.67
2.31 ± 1.79
0.0386
EDD
< 56, n = 142
≥ 56, n = 20
4.22 ± 4.82
5.27 ± 4.88
0.379 2.40 ± 1.79
2.82 ± 1.83
0.4508
LA
< 40, n = 98
≥ 40, n = 64
4.20 ± 4.96
4.31 ± 4.71
0.592 2.30 ± 1.78
2.53 ± 1.85
0.4152
MR
1–2, n = 104
3, n = 13
4.22 ± 4.84
7.00 ± 9.64
0.811 2.29 ± 1.75
2.67 ± 2.08
0.6380
AS
1–2, n = 19
3, n = 9
5.56 ± 6.26
3.00 ± 1.63
0.963 2.38 ± 2.00
3.50 ± 0.58
0.4372
AR
1–2, n = 63
3, n = 0
4.60 ± 5.47
-
- 2.56 ± 1.80
-
-
Concentric RWT hypertrophy
absent, n = 101
present, n = 61
4.46 ± 4.92
4.02 ± 4.68
0.4393 2.32 ± 1.75
2.62 ± 1.86
0.3183
Eccentric RWT hypertrophy
absent, n = 108
present, n = 54
4.31 ± 5.13
4.27 ± 4.01
0.3120 2.48 ± 1.79
2.31 ± 1.81
0.5536
NIHSS — National Institute of Health Stroke Scale, LV — left ventricle, EF — ejection fraction, EDD — end-diastolic dimension, LA — left atrium, MR — mitral 
regurgitation, AS — aortic stenosis, AR — aortic regurgitation, RWT — relative wall thickness 
Table 3. Neurological status on the 1st day and functional status at 30 days after stroke onset depending on the velocity of mitral inflow E / A
Group 1 
E/A ≤ 0.8 
n = 79
Group 2 
0.8  >  E/A < 2 
n = 70
Group 3 
 E/A ≥ 2 
n = 13
1 vs 2 1 vs 3 2 vs 3
NHISS** 3.41 ± 3.36 
[0–16] median 3
5.43 ± 5.92 
[0–22] median 3
1.67 ± 1.53 
[0–3] median 2
0.2388 0.3800 0.2874
Rankin** 2.16 ± 1.67 
[0–5] median 2
2.74 ± 1.91 
[0–6] median 3
2.33 ± 2.08 
[0–4] median 3
0.0445 0.9419 0.6416
** U Mann-Whitney Test; NIHSS — National Institute of Health Stroke Scale
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above observations concern patients with cryptogenic stroke. 
They can result from coexisting with LVDD undetected AF. 
LVDD is a recognised risk factor for AF, and it can be asso-
ciated with the progression and symptom severity of AF, and 
it is also an indirect factor for systemic embolism [21, 22]. 
Together with LVDD, silent AF can also coexist. According to 
the results of the present study, E/A dysfunctions have a de-
trimental effect on patients’ functional state one month after 
the onset of stroke. This sheds new light on the importance of 
diastolic dysfunction for the possibility of neurological state 
improvement following acute incidence of cerebral ischae-
mia. Many studies have shown that LVSD with low EF is only 
a risk factor for stroke, although there have been reports that 
do not support such a correlation [23–26]. According to the 
WARCEF trial, only EF < 15% is associated with an increased 
risk of stroke (HR 2.125, 95% CI, 1.182–3.818, p = 0.012) [27]. 
As we have demonstrated in this study, coexistence of low 
ejection fraction has been associated with adverse effect of 
LVDD on prognosis in the acute and subacute stage of cerebral 
infarct. Furthermore, the effect of LVDD varies depending 
on its severity.
In summary, the results of this study indicate that the 
presence of LVSD and/or LVDD is a worse prognostic factor 
in patients in the acute stage of stroke. It has been documen-
ted that heart dysfunction (HD) has an adverse effect on the 
functional status of patients in the chronic stage of stroke, and 
that this effect is independent of the treatment used, including 
thrombolysis [28–30].
The results obtained in this study also confirm the inde-
pendent-of-therapy impact of HD. It is difficult to determine 
what percentage of stroke patients suffer from HD and are at 
risk of its decompensation, as well as in which patients HD is 
likely to have a significant impact on the neurological status. 
Over-activation of the vegetative system during stroke in 
patients with preexisting heart disorders may lead to exacer-
bation of cardiac dysfunction. Due to the differing definitions 
of HD, prevalence data is inconsistent. Elderly patients with 
other comorbidities are in the higher risk group [29, 31].
The present study highlights the role of echocardiography 
in the structural and functional assessment of heart function 
and in finding abnormalities that may have clinical implica-
tions in stroke survivors. TTE may be useful in the planning 
of post-stroke rehabilitation due to the need to modify it in 
case of left ventricular dysfunction.
Limitations
The lack of an analysis of the impact of the type of stro-
ke (aetiology) or the size of ischaemic focus on the stroke 
outcome.
Conclusions
Nearly one quarter of patients in the acute phase of stroke 
have features of systolic and / or diastolic dysfunction of the 
left ventricle.
Left ventricular dysfunction adversely affects both neuro-
logical status in the acute stage of stroke as well as functional 
status in the short-term follow-up.
Age at first stroke incidence and lower ejection fraction 
during the acute phase of illness are predictors of poor fun-
ctional status one month after stroke.
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